Jiangxi Huabang Pharmaceuticals Co., Ltd is professional in the production of antibiotic APIs and intermediates. Currently, main products are tazobactam sodium, tazobactam acid and intermediate, sulbactam sodium, sulbactam acid and intermediate, meropenem side chain and Sultamicillin intermediate. Most of them have been exported to several regions and countries such as Europe, America, South-east Asia.
    Nanjing Pharmacare invested Huabang in 2018 and take fully responsibility for international market. Integration of upstream and downstream reduce production costs of tazobactam acid and strengthen advantage. Strategic cooperation has established with various famous customers.
    Pharmacare extends downstream actively and has formed complete industry chain covering from tazobactam acid intermediate, tazobactam acid and piperacillin sodium and tazobactam sodium 8:1 sterile powder, which enhance market influence and competitiveness.
    Meanwhile, Pharmacare pay attention to the development of regular market and the workshops which meets the requirements of European, American, Japanese and domestic markets for tazobactam acid have been set up. Synchronous submission will be made in 2021 after DMF completed. We will try our best to satisfy the needs of various clients and improve our share of the market.

    Mrs.Angela,+86-25-86622924, angela@fmkpharm.com

    Mr.Cheney,+86-25-86622945,cheney.zhu@fmkpharm.com